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		Synopsis


SYNOPSIS
This thesis entitled “Towards the synthesis of bio-active molecules: Amphidinolide X, (+)-Goniodiol, (−)-Pinellic acid, (+)-trans-Cognac lactone and (+)-trans-Aerangis lactone” has been divided into four chapters.
Chapter I: 	Towards the synthesis of Amphidinolide X.
Section A:  This section deals with the introduction and previous approaches of the Amphidinolide X.
Section B: 	This section deals with the present work of the Amphidinolide X.
Chapter II: 	Total synthesis of (−)-Pinellic acid and its 9R-diastereomer.
Section A: 	This section describes the introduction and previous approaches of the (−)-Pinellic acid and its 9R-diastereomer.
Section B: 	This section describes the present work of (−)-Pinellic acid and its 9R-diastereomer.
Chapter III: Total synthesis of (+)-Goniodiol, (+)-trans-Cognac lactone and (+)-trans-Aerangis lactone.
Section A:  	This section describes the introduction, previous approaches and present work of the (+)-Goniodiol.
Section B:	This section narrates the introduction, previous approaches and present work of the (+)-trans-Cognac lactone and (+)-trans-Aerangis lactone.
Chapter IV:	A Sakurai-Prins-Ritter reaction sequence for the diastereoselective synthesis of 4-amidotetrahydropyrans catalyzed by bismuth triflate.
Section A:   This section describes the introduction and previous approaches of the 4-amidotetrahydropyrans.
Section B:     This section describes the present work of 4-amidotetrahydropyrans.

CHAPTER I: Towards the synthesis of Amphidinolide X
Natural products from the marine origin continue to be the most promising class of architecturally complex structures and display a wide variety of biological activities. Impressive biological profiles in conjunction with their low abundance and challenge posed by these structurally intriguing compounds for their synthesis continue to elude the worldwide synthetic community. Amphidinolide X, a 16-membered marine macrolide consisting of polyketide derived diacid and diol units, isolated from the laboratory cultured dinoflagellates Amphidinium sp. (Strain Y-42) which are symbionts of the Okinawan flatworms Amphiscolops sp.1 Amphidinolide X (1) exhibits cytotoxic activity against L1210 and KB cell lines.2 Its structural novelty, low abundance, activity against human cell lines, made the Amphidinolide X (1) as an important and challenging synthetic target. Herein we describe our efforts towards the synthesis of Amphidinolide X (1).
Retrosynthetic analogy for the synthesis of Amphidinolide X (1) was outlined in Scheme 1. While the ester linkages forming the macrolide ring constitute obvious sites of dissection, it was envisaged to assemble the C7-C22 segment by metal promoted cross coupling at C14-C15 bond. This strategy confers three similar sized fragments 3 (C15-C22), 4 (C7-C14) and 5 (C1-C6) for the highly convergent synthesis of 1.

   






















Scheme 1: Retrosynthetic analysis of Amphidinolide X
Synthesis of C15-C22 fragment 3: 
Retrosynthetic strategy for fragment 3 of Amphidinolide X (1) was depicted as in Scheme 2. It has been envisaged that fragment 3 can be prepared by functional group modifications from compound 6 which could be obtained from compound 7 by an intramolecular SN2 reaction. Compound 7 can be prepared from the diol 8 which in turn could be easily derived from the commercially available R-linalool 10.


	









Scheme 2: Retrosynthetic strategy for fragment 3.
Synthesis of C15-C22 segment 3 commenced from the compound 9 which can be readily derived from the R-linalool 10 as reported.3 Compound 9 was smoothly converted to diol 8 in 90% yield by hydroboration followed by subsequent treatment with alkaline hydrogen peroxide.4 Aldehyde prepared by oxidation of diol 8 using Tempo-BAIB in CH2Cl2 at room temperature, was subjected to two carbon elongation in one-pot using ethoxycarbonylmethylene triphenylphosphine (Ph3PCHCOOEt) to afford the trans-α,β-unsaturated ester 11 in 82% yield. Direct asymmetric dihydroxylation of compound 11 gave unsatisfactory yields. Hence, we first protected the free hydroxyl group of 11 to its corresponding silyl ether 12 using TBSOTf and lutidine in CH2Cl2 in 92% yield. Compound 12 was then subjected to Sharpless asymmetric dihydroxylation using AD-mix-β, CH3SO2NH2 in t-BuOH and water (1:1) at 0 oC to afford the desired diol 13 in 80% yield (Scheme 3). The α-hydroxyl group of α,β-dihydroxy ester 13 was selectively tosylated using tosylchloride and Et3N in CH2Cl2 to afford the compound 14 in 68% yield. Mono tosylated compound 14 in hand, we anticipated the SN2 reaction by protecting the free hydroxyl group.










 





Scheme 3
But, efforts to protect the free hydroxyl group in compound 14 were unsuccessful. However, the in-situ deprotection of silyl ether and SN2 reaction with TBAF also failed to give the desired substituted tetrahydrofuran. Whereas, acid catalyzed tandem deprotection, cyclization resulted in a mixture of unknown products. The above results forced us to revise the synthetic strategy for the fragment 3. 
Revised synthesis of C15-C22 fragment 3:



	





Scheme 4: Revised retrosynthetic strategy for fragment 3.
Revised retrosynthetic strategy of fragment 3 for Amphidinolide X (1) was depicted in Scheme 4. It has been envisaged that an intramolecular iodoetherification5 of allylic alcohol 15, subsequent protection of free hydroxyl group would give the C15-C22 segment (3). Allylic alcohol 15 can be obtained from the diol 8.
Compound 8 on treatment with benzaldehyde dimethyl acetal in presence of catalytic amount of camphorsulphonic acid (CSA) in dry CH2Cl2 provided the benzyl acetal 17 in 90% yield. Regioselective opening of 17 was achieved by treating with DIBAL-H in dry CH2Cl2 towards the required primary alcohol 16 in 92% yield. Oxidation of compound 16 using IBX in DMSO furnished aldehyde, which was used for next step without further purification. Thus, the crude aldehyde was treated with vinylmagnesium bromide to afford the inseparable diastereomeric mixture of allylic alcohol 18 which on oxidation with bicarbonate buffered Dess-Martin Periodinane provided the enone 19 in 66% yield (Scheme 5). At this juncture, it is necessary to establish chiral center at C17. To this end, the prochiral ketone 19 was reduced with S-(Me)-CBS catalyst6 in presence of BH3.SMe2 to afford the allylic alcohol 15 with required stereochemistry in 70% yield (99% de).














Scheme 5
Compound 15 was subjected to an intramolecular iodoetherification reaction by treating with molecular iodine in CH3CN at −20 oC to furnish the key tetrahydrofuran moiety 20 in 66% yield. Compound 20 was then converted to its corresponding MOM ether by treating with MOM-Cl in presence of Hunig’s base in CH2Cl2 to afford the subunit 3 in 90% yield (Scheme 5). 
Synthesis of C7-C14 fragment 4:










Scheme 6: Retrosynthetic analysis of fragment 4.
Retrosynthetic analysis of fragment 4 was outlined in Scheme 6. As per the planned retrosynthesis, fragment 4 can be prepared from compound 21 by two sequential functional group modifications. Compound 21 could be obtained by regioselective epoxide opening7 of compound 22, subsequent silyl protection. Compound 22 in turn easily derived from the propargylic alcohol 23 and allyl bromide 24.  
Synthesis of C7-C14 fragment 4 was began from propargylic alcohol 23, which was treated with allyl bromide 24 in presence of Na2CO3/TBAI and CuI to afford the allylated product 25 in 82% yield (Scheme 7). Compound 25 was reduced with LAH in THF to afford the E-allylic alcohol 26 (80% yield) which on treatment with (+)-DET, titanium isopropoxide and cumene hydroperoxide in CH2Cl2 at −24 oC furnished the epoxy alcohol 27 in 86% yield. Compound 27 was oxidized using IBX and subsequent Wittig olefination with corresponding phopshorane (Ph3PC(CH3)COOEt) furnished the α,β-unsaturated epoxide 22 in 80% yield with required geometry. Later, methyl centre at C11 was introduced by employing regioselective epoxide opening reaction. Accordingly, compound 22 was exposed to Me3Al in CH2Cl2 at −40 oC to afford the compound 28 in 78% yield as a single isomer. The compound 28 was protected as its silyl ether 21 by treating with TBSOTf in presence of lutidine, which was then reduced to allylic alcohol 29 using DIBAL-H in CH2Cl2 at 0 oC in 92% yield. The compound 29 was converted to its iodide 4 by treating with molecular iodine in presence of TPP and imidazole in CH2Cl2 at 0 oC to room temperature in 84% yield.














Scheme 7
	In conclusion, brisk synthesis of C7-C14 (4), C15-C22 (3) sub-units of Amphidinolide X (1) has been achieved in 17 steps with hydroboration, CBS-reduction, iodo etherification, Sharpless asymmetric epoxidation and regioselective epoxide opening reactions as key steps and further efforts are in progress for the total synthesis of Amphidinolide X.  
CHAPTER II: Total synthesis of (−)-Pinellic acid and its 9R-diastereoisomer.
Kampo medicine, ‘Sho-seiryu-to’ was found to possess potent adjuvant activity by oral administration on nasal influenza infection and nasal influenza vaccination.8 (−)-Pinellic acid 30 was responsible for its adjuvant activity isolated from pinelliae tuber, one of the component herbs of the Kampo formula, ‘Sho-seiryu-to’ (SST).9 All the isomers of pinellic acid were isolated from pinelliae tuber and their stereochemistry was assigned by Omura and co-workers.10 Pinellic acid 30 is a novel and potentially useful oral adjuvant when used in conjunction with intranasal inoculation of influenza HA vaccines.9a Among the series of pinellic acid isomers, the (9S,12S,13S)-compound (30), exhibited the most potent adjuvant activity.10c












Scheme 8: Retrosynthesis of pinellic acids
The synthesis of 9S,12S,13S pinellic acid 30 and its 9R,12S,13S diastereoisomer 31 started from a single chiral building block 35. The known chiral aldehyde11 35 derived from (+)-DET 36 was subjected to Wittig olefination reaction with n-butylphosphonium bromide in the presence of potassium t-butoxide in THF to provide the corresponding olefinic compound 37 in 70% yield. Removal of the benzyl protecting group with concomitant reduction of the C=C bond was easily performed by hydrogenation at atmospheric pressure, in AcOEt in the presence of 10% Pd/C as the catalyst to afford a saturated alcohol 38 in 96% yield (Scheme 9). Oxidation of the primary hydroxy group and subsequent Wittig reaction with the stable two carbon ylide, furnished unsaturated ester 34 (80% yield over two steps). Reduction of the ester group with DIBAL-H in CH2Cl2 at −78 oC afforded an unstable enal, which, without isolation, was subjected to a Grignard reaction with THP protected bromide 39. The reaction yielded a diastereomeric mixture of secondary alcohols 40 and 41 in a 1.5:1 ratio. These two isomers were separated by column chromatography and whose stereo chemical assignments were confirmed on later stage. Compound 41 was converted into 40 by inversion of the configuration under standard Mitsunobu conditions (DIAD, Ph3P, and p-nitro benzoic acid)












Scheme 9
The secondary hydroxyl group in 40 was protected as its methoxymethyl ether 32, and subsequent removal of the THP group with catalytic pyridinium para toluene sulphonate in MeOH led to the formation of 42 at room temperature. This alcohol was oxidized with iodoxybenzoic acid reagent in DMSO and CH2Cl2 to afford aldehyde, 










Scheme 10
which on subsequent oxidation with NaClO2, NaH2PO4 in DMSO and water, afforded the corresponding acid 43 in 75% yield (Scheme 10). Finally, the acetonide and MOM groups were deprotected under acidic conditions (HCl in MeOH) to afford the target molecule 30 in 66% yield. The physical and spectroscopic data of 30 were identical with those reported.










Scheme 11
Similarly, compound 41 was taken through all the steps described above leading to the formation of 31 (Scheme 11). The structure of 31 was confirmed from spectral and analytical data.
In conclusion, we have accomplished a simple and straightforward synthesis of the (−)-pinellic acid and its 9R-diasteoisomer, potent oral adjuvants for the influenza vaccines.
CHAPTER III: 
Section A: Total synthesis of (+)-Goniodiol.
Styryl lactones are a series of natural products, exhibiting moderate to significant biological activity including antitumor and antifungal properties, as well as antibiotic potential.12 (+)-Goniodiol 46, an oxygenated 6-dihydrostyryl-5,6-dihydro-2-pyrone, was isolated from the leaves and twigs of Goniothalamus sesquipedalis (Annonaceae)12a and the stem bark of Thai Goniothalamus giganteus.12b Goniodiol exhibited potent selective cytotoxicity against human lung carcinoma cell lines A-549,12c HL-60 cells,13 and P-388 murine leukemia cells.14
Retrosynthetic route for (+)-Goniodiol
In our retrosynthetic analysis (Scheme 12), we envisaged that the target molecule 46 could be prepared through acid catalyzed cyclization of compound 47 which was obtained from allylic alcohol 48 which in turn could be easily derived from benzaldehyde 49 and protected homo propargylic alcohol 50.





 




Scheme 12: Retrosyntheis of (+)-Goniodiol
The synthesis of (+)-Goniodiol 46  commenced with the Carreira alkynylation reaction of benzaldehyde 49 with p-methoxybenzyl ether of homopropargylic alcohol 50 in the presence of (+)-N-methyl ephedrine, zinc triflate and triethylamine15 to afford the chiral propargylic alcohol 51 in 88% yield with high enantioselectivity. On the other hand, compound 51 can be prepared by an alternative route as shown in scheme 13. Accordingly, benzaldehyde 49 was treated with PMB ether of homopropargylic alcohol 50 in presence of LHMDS to afford compound 52, which on oxidation with IBX in 











Scheme 13
DMSO, CH2Cl2 afforded the corresponding ketone 53. Ketone 53 on asymmetric reduction16 with R-(Me)-CBS catalyst in presence of BH3.SMe2 resulted in chiral propargylic alcohol 51 in 66% yield with excellent 99% ee (Scheme 13).
Compound 51 on partial reduction with LAH in THF furnished E-allylic alcohol 48. The secondary hydroxyl group of compound 48 was protected as its MOM ether 54 by treating with MOM-Cl in presence of Hunig’s base in 92% yield. The compound 54 was then converted to syn-diol 55 by employing Sharpless asymmetric dihydroxylation conditions. Thus, the compound 54 was treated with AD-mix-β in t-BuOH-H2O (1:1) to afford diol 55 as a single isomer in 90% yield.

  	















Scheme 14
Subsequent acetonide protection of hydroxyl groups followed by the deprotection of PMB ether with H2-Pd/C furnished the compound 57 in 96% yield (Scheme 14). Oxidation of alcohol 57 to its corresponding aldehyde and subsequent chain elongation17 with Still-Gennari reagent furnished the Z-enone 47 in 82% yield along with traces of E-isomer. Compound 47 on treating with catalytic amount of p-TsOH in EtOH at 50 oC resulted in target molecule 46 by tandem deprotection, in-situ cyclization process. Spectral and analytical data of compound 46 were in agreement with the natural product. 
       In summary, the total synthesis of (+)-goniodiol, a cytotoxic styryl lactone was accomplished in a stereocontrolled manner by the creation of chiral centers via Carreira alkynylation or CBS-reduction and Sharpless asymmetric dihydroxylation reactions with good overall yield.
Section B: Total synthesis of the (+)-trans-Cognac lactone and (+)-trans-Aerangis lactone
       The γ-lactones (five-membered) and δ-lactones (six-membered) functionalized at the ring carbons are useful as building blocks in natural product syntheses and are used in the perfume industry. The cis- and trans- cognac lactones were isolated from different types of wood, and they were identified as key flavors of aged alcoholic beverages such as whisky, brandy, wine, and cognac.18 
       Aerangis lactones are natural fragrant molecules identified from the Aerangis species (native to Kenya and Tanzania). The cis and trans isomers were found to show a very pleasant odor, reminiscent both of the smell of tuberose and gardenia and of the fragrance of caramel, condensed milk, and coconut.19 We herein report a radical cyclization route for the synthesis of (+)-trans-cognac lactone (58) and (+)-trans-aerangis lactone (59).











Scheme 15: Retrosynthetic analysis of cognac and aerangis lactones
       In our retrosynthesis, it has been envisaged that (+)-trans-aerangis lactone 59 and (+)-trans-cognac lactone 58, could be synthesized from the key intermediate 60. The intermediate 60 can be prepared from a chiral epoxy alcohol 61 as given in Scheme 15.
 The synthesis of the two lactones 58 and 59 began with the E-allyl alcohol 62 (Scheme 16). The alcohol 62 was subjected to Sharpless epoxidation conditions using diisopropyl-D-(−)-tartarate (DIPT), Ti(OiPr)4, and cumene hydroperoxide in CH2Cl2 at −24 oC to afford 2,3-epoxy alcohol 61 in 78% yield. The epoxy alcohol 61 was converted to the corresponding 2,3-epoxy-1-chloride 63 by treatment with TPP in refluxing CCl4 for 4 h. Reductive opening of 63 was achieved with Na in ether to furnish the desired chiral allyl alcohol 64 in 70% yield.Treatment of 64 with N-bromosuccinamide and ethyl vinyl ether in CH2Cl2 afforded the bromoacetal 65.20 The key step of the synthesis was the radical cyclization, which could be achieved by treatment of bromoacetal 65 with n-Bu3SnH, catalytic amount of AIBN (as a radical initiator), in refluxing benzene21 for 2 h to give the cyclic ethyl acetal 66. The cyclic acetal 66 was hydrolyzed using 60% AcOH under refluxing conditions to give a key intermediate lactol 60.













Scheme 16
Lactol 60 on oxidation with pyridiniumchlorochromate (PCC) in CH2Cl2 afforded the target molecule 58 in 92% yield. The stereochemistry of the lactone 58 was established to be trans by NMR spectral analysis, which showed a methyl resonance at 1.01 (d, J = 5.9 Hz) and H-5 at 3.82–3.94 (m, 1H), and also comparing the natural product spectral and optical rotation data. 
      The synthesis of trans-aerangis lactone 59 was achieved from the key intermediate lactol 60 as shown in scheme 17. Thus, chain elongation by one carbon atom was achieved via one-carbon Wittig olefination reaction with methyltriphenylphosphonium iodide in the presence of t-BuOK to afford the homologated compound 67 in 53% yield. The secondary hydroxyl group in compound 67 was protected as its methoxymethyl (MOM) ether 68 by treatment with MOMCl, in the 










Scheme 17
presence of Hunig’s base in CH2Cl2. Hydroboration of 68 using BH3.THF afforded a primary hydroxy compound 69 in 88% yield. The alcohol 69 was subjected to oxidation using IBX in CH2Cl2–DMSO to afford the aldehyde; without isolation it was further oxidized to the corresponding acid 70 using NaClO2 and NaH2PO4 in DMSO. Acid was also used directly for the next step without further purification. Thus, acid 70 on treatment with p-TsOH in MeOH produced the target molecule 59 by deprotection of MOM group followed by in situ cyclization. Its spectral data and specific rotation were in complete agreement with those reported for the natural product.
      In summary, we have described an elegant radical-based strategy for the synthesis of disubstituted five-and six-membered lactones, (+)-trans-cognac lactone (58) and (+)-trans-aerangis lactone (59), from the same key intermediate.
CHAPTER IV: A Sakurai-Prins-Ritter reaction sequence for the diastereoselective synthesis of 4-amidotetrahydropyrans catalyzed by bismuth triflate
       Functionalized tetrahydropyrans constitute key structural motifs of a large number of biologically active natural products. Amino tetrahydropyrans are important structural motifs of a wide range of natural products such as ambruticins, oligomers of glucoamino acids, sialic acid and desyherbaine. These compounds are also used in photographic films22 and host-guest chemistry.23 Examples of the Sakurai-Prins-Ritter (three reactions) in a single step, for the synthesis of symmetric 2,6-disubstituted-4-acetamidotetrahydropyrans are limited24 and it has not been explored extensively. 
We report herein an expedient direct synthesis of all-cis 2,4,6-trisubstituted tetrahydropyrans via a Sakurai-Prins-Ritter reaction sequence mediated by Bi(OTf)3.4H2O. Initially, 2 equiv of benzaldehyde was treated with 1 equiv of allyltrimethylsilane in acetonitrile in the presence of 10 mol% Bi(OTf)3.4H2O at room temperature, resulting in 4-acetamido-2,4- tetrahydropyran in 85% yield with high diastereoselectivity (Scheme 18). The reaction was found to be very fast and was complete within 45 min.



Scheme 18
Under similar conditions, various other aldehydes were reacted to afford the corresponding 4-acetamidotetrahydropyrans (Table 1). All the reactions are highly diastereoselective and from the 1H and 13CNMR spectra it was apparent that a single product had been isolated in each reaction. Similarly, the one-pot Sakurai-Prins-Ritter reaction of aldehydes and allyltrimethylsilane proceeded in the presence of other nitriles such as benzonitrile, 4-methylbenzonitrile and iso-butyronitrile providing the corresponding products in good yields with high diastereoselectivity as determined from the 1H NMR spectra of the crude products. In all cases, the three substituents occupied equatorial positions. The results are indicated in Table 2. This catalytic method offers several advantages including mild conditions, rapid, no formation of byproducts and does not require an inert atmosphere.
 
















































In conclusion, we have developed an efficient one-pot, Sakurai-Prins-Ritter reaction mediated by bismuth triflate to furnish 4-amidotetrahydropyrans.

REFERENCES
1.	Tsuda, M.; Izui, N.; Shimbo, K.; Sato, M.; Fukushi, E.; Kawabata, J.; Katsumata, K.; Horiguchi, T.; Kobayashi, J. J. Org. Chem. 2003, 68, 5339.
2.	Tsuda, M.; Izui, N.; Shimbo, K.; Sato, M.; Fukushi, E.; Kawabata, J.; Kobayashi. J. J. Org. Chem. 2003, 68, 9109.
3.	 (a) Mori, K. Tetrahedron 1977, 33, 289; (b) Tago, K.; Arai, M.; Kogen, H. J. Chem. Soc. Perkin Trans I 2000, 2073. 
4.	Jung, M.; Ham, J.; Song, J. Org. Lett. 2002, 4, 2763.
5.	White, J. D.; Quaranta, L.; Wang, G. J. Org. Chem., 2007, 72, 1717.
6.	Semmelhack, M. F.; Hooley, R. J.; Kraml, C. M. Org. Lett. 2002, 4, 2763.
7.	Miyashita, M.; Hoshima, M.; Yoshikoshi, A. J. Org. Chem. 1991, 56, 6483.
8.	a) Miyamoto, T. Asian Med. J. 1992, 35, 30; b) Nagai, T.; Yamada, H. Int. J. Immunopharmacol. 1994, 16, 605.
9.	a) Kato, T.; Yamaguchi, Y.; Ohnuma, S.; Uyehara, T.; Namai, T.; Kodama, M.; Shiobara, Y. Chem. Lett. 1986, 577; b) Funk, C. D.; Powell, W. S. Biochem. Biophys. Acta 1983, 754, 57; c) Hanberg, M. Lipids 1991, 26, 407.
10.	a) Sunazuka, T.; Shirahata, T.; Yoshida, K.; Yamamoto, D.; Harigaya, Y.; Nagai, T.; Kiyohara, H.; Yamada, H.; Kuwajima, I.; Omura, S. Tetrahedron Lett. 2002, 43, 1265; b) Shirahata, T.; Sunazuka, T.; Yoshida, K.; Yamamoto, D.; Harigaya, Y.; Nagai, T.; Kiyohara, H.; Yamada, H.; Kuwajima, I.; Omura, S. Bioorg. Med. Chem. Lett. 2003, 13, 937; c) Shirahata, T.; Sunazuka, T.; Yoshida, K.; Yamamoto, D.; Harigaya, Y.; Nagai, T.; Kiyohara, H.; Yamada, H.; Kuwajima, I.; Omura, S. Tetrahedron 2006, 62, 9483.
11.	Lu, W.; Zheng, G.; Haji, Aisa, A.; Cai, J. Tetrahedron Lett. 1998, 39, 9521. 
12.	 a) Talapatra, S. K.; Basu, D.; Goaswami, S.; Talapatra, B. Indian J. Chem. B 1985, 24, 29; b) Alkofahi, A.; Ma, W. W.; Mckenze, A. T.; Byrn, S. R.; Mclaughlin, J. L. J. Nat. Prod. 1989, 52, 1371; c) Fang, X. P.; Anderson, J. E.; Chang, C. J.; Mclaughlin, J. L.; Fanwick, P. E. J. Nat. Prod. 1991, 54, 1034.
13.	Nakashima, K.; Kikuchi, N.; Shirayama, D.; Miki, T.; Ando, K.; Sono, M.; Suzuki, S.; Kawasw, M.; Kondoh, M.; Sato, M.; Kanai, K.; Nagase, H.; Honda, T. Bull. Chem. Soc. Jpn. 2007, 80, 387.
14.	Tsubuki, M.; Kanai, K.; Nagase, H.; Honda, T. Tetrahedron 1999, 55, 2493.
15.	a) Boyall, D.; Frantz, D. E.; Carreira, E. M. Org. Lett. 2002, 4, 2605; (b) Fettes, A.; Carreira, E. M. J. Org. Chem. 2003, 68, 9274.
16.	(a) Wendt, K. U.; Schulz, G. E.; Liu, D. R.; Corey, E. J. Angew. Chem. Int. Ed. 2000, 39, 2812. (b) Corey, E. J.; Shibata, S.; Bakshi, R. K. J. Org. Chem. 1988, 53, 2861. (C) Scheerer, J. R.; Lawrence, J. F.; Wang, G. C.; Evans, D. A. J. Am. Chem. Soc. 2007, 129, 8968.
17.	Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405.
18.	a) Kepner, R. E.; Webb, A. D.; Muller, C. J. Am. J. Enol. Vticult. 1972, 23, 103; b) Otsuka, K.; Zenibayashi, Y.; Itoh, M.; Totsuka, A. Agric. Biol. Chem. 1974, 38, 485; c) ter Heide, R.; Devalois, P. J.; Visser, J.; Jeagers, P. P.; Timer, R. In Analysis of Food and Beverages: Charalambous, G. ; Ed.; Acadamic Press: New York, 1978, 275.
19.	a) Kaiser, R. The Scent of Orchids, Olfactory and Chemical Investigations; Editions Roche, F. Hoffmann La. Roche, AG Basel, Elsevier: 1993; b) Barschat, D.; Lehmann, D.; Dietrich, A.; Mosandl, Kaiser, R. Phytochem. Anal. 1995, 6, 130.
20.	Heckmann, C.; Schafer, H. J. Tetrahedron 1993, 49, 4459.
21.	a) Stork, G.; Mook, R. Jr.; Biller, S. A.; Rychnovsky, S. D. J. Am. Chem. Soc. 1983, 105, 3741; b) Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734.
22.	Sakata, H.; Yasukawa, H. Jpn. Kokai Tokkyo Koho JP 2003121964 A, 2003, 42 pp.
23.	McGarvey, G. J.; Stepanian, M. W.; Bressette, A. R.; Sabat, M. Org. Lett. 2000, 2, 3453.
24.	a) Epstein, O. L.; Rovis, T. J. Am. Chem. Soc. 2006, 128, 16480; b) Reddy, U. C.; Raju, B. R.; Kumar, E. K. P.; Saikia, A. K. J. Org. Chem. 2008, 73, 1628.




 EMBED ChemDraw.Document.6.0  















































PAGE  



I



